{
  "run_id": "repurpose-2026-02-07T23-13-17-120Z",
  "updated_at": "2026-02-07T23:13:17.122Z",
  "total": 3,
  "signals": [
    {
      "signal_id": "repurpose-compound-ax-17-example-osteoarthritis-01",
      "compound": "Compound AX-17 (example)",
      "proposed_species": [
        "canine"
      ],
      "proposed_condition": "Osteoarthritis",
      "confidence_score": 28,
      "risk_overall": 35,
      "summary_hypothesis": "Research hypothesis: Compound AX-17 (example) may warrant evaluation for Osteoarthritis in canine.",
      "executive_summary": [
        "Compound AX-17 (example): Primary endpoint did not reach statistical significance in target population. Enrollment skewed toward late-stage disease, limiting responsiveness.",
        "Canine inflammatory response may be more responsive to short-term modulation.",
        "Veterinary evidence is weak with 1 cited item(s). Evidence remains limited.",
        "Risk profile is moderate (35/100) with flagged contraindications requiring review."
      ],
      "disclaimer": "Research hypothesis only; not medical advice."
    },
    {
      "signal_id": "repurpose-compound-rn-44-example-chronic-kidney-disease-02",
      "compound": "Compound RN-44 (example)",
      "proposed_species": [
        "feline"
      ],
      "proposed_condition": "Chronic kidney disease",
      "confidence_score": 27,
      "risk_overall": 55,
      "summary_hypothesis": "Research hypothesis: Compound RN-44 (example) may warrant evaluation for Chronic kidney disease in feline.",
      "executive_summary": [
        "Compound RN-44 (example): Insufficient bioavailability at planned dosing window.",
        "Feline CKD progression windows may allow earlier intervention.",
        "Veterinary evidence is moderate with 1 cited item(s). Evidence remains limited.",
        "Risk profile is moderate (55/100) with flagged contraindications requiring review."
      ],
      "disclaimer": "Research hypothesis only; not medical advice."
    },
    {
      "signal_id": "repurpose-compound-lm-12-example-laminitis-03",
      "compound": "Compound LM-12 (example)",
      "proposed_species": [
        "equine"
      ],
      "proposed_condition": "Laminitis",
      "confidence_score": 12,
      "risk_overall": 72,
      "summary_hypothesis": "Research hypothesis: Compound LM-12 (example) may warrant evaluation for Laminitis in equine.",
      "executive_summary": [
        "Compound LM-12 (example): Trial endpoints focused on short-term perfusion and missed chronic outcomes.",
        "Equine laminitis endpoints differ from human perfusion metrics.",
        "Veterinary evidence is weak with 1 cited item(s). Evidence remains limited.",
        "Risk profile is high. Not recommended for further pursuit."
      ],
      "disclaimer": "Research hypothesis only; not medical advice."
    }
  ]
}